The Coca-Cola Company has recalled some Sprite, Fanta, and Diet Coke batches. The beverage manufacturer takes about 2,000 cases of the said drinks off the market shelves.
As per NBC News, the U.S. Food and Drug Administration (FDA) announced the recall through a filing. While this event was only publicized this week, the food and drug authority said the call back of Coca-Cola’s Sprite, Diet Coke, and Fanta actually started last month.
Reason for the Recall and Affected Products
The FDA revealed that Coca-Cola’s latest beverage recall involves 1,557 cases of Sprite in 12-ounce cans with the Best By date of 07/29/24, 417 cases of Diet Coke (Best By 01/29/24), and 14 cases of Fanta Orange (Best By 07/29/24). The particular batches affected by the recall were said to have been manufactured by United Packers, which is located in Alabama.
The recalled drinks were distributed in three states: Florida, Alabama, and Mississippi. The main reason for the recall is the potential presence of foreign material in the canned drinks. Coca-Cola said no other products besides the three mentioned brands and batches are affected.
Update on the Recall
In a statement that Coca-Cola’s representative shared with PEOPLE, the company has completed all the recall activities in the affected market. Then again, the “foreign material” type found in the soft drinks was not specified in the reports.
Meanwhile, Today reported that this is not the first time Coca-Cola issued a recall for the same reason of possible “foreign material” contamination. In 2021, the beverage maker recalled several variants of its Minute Maid juice products because some foreign metal objects were suspected to have tainted the drinks. At that time, about 7,000 cases of the voluntarily recalled juice were classified by the FDA as Class II recall.
Photo by: Senad Palic/Unsplash


SpaceX IPO Nears as Goldman Sachs Set to Lead Historic $75 Billion Offering
TSMC Stake Sale Sends Vanguard Semiconductor Shares Lower
Samsung, Union Edge Closer to Deal as Strike Threat Looms
OpenAI Expands Globally with First Overseas AI Lab in Singapore
Anthropic to Brief Financial Stability Board on AI-Driven Cyber Risks
Thyssenkrupp to Shut Down Indiana Automotive Plant by March 2026
OpenAI Eyes IPO Filing as Early as This Week Amid Rising AI Competition
X Corp Loses Legal Battle Over Australia Child Safety Fine
GameStop Raises eBay Stake to 6.6% as Ryan Cohen Pushes $56 Billion Takeover Bid
Google Expands AI Partnership With Singapore Government
Anthropic Revenue Surge Signals Strong AI Market Momentum in 2026
Sonova Beats Profit Forecasts Despite Cochlear Implant Weakness
TrumpRx Expands Discount Drug Access With 600 Generic Medications
Blackstone and Google Launch AI Cloud Venture, Pressuring CoreWeave and Nebius Shares
JPMorgan Sees Large-Cap Biotech Stocks Entering New Growth Phase in 2026 



